NCT06107543View on ClinicalTrials.gov

Lidocaine in the Prevention of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation

CompletedOBSERVATIONAL
Enrollment

94

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

June 1, 2024

Study Completion Date

June 22, 2024

Conditions
Lidocaine
Interventions
DRUG

Nebulized Lidocaine

Before induction of anesthesia, 2% lidocaine + physiological saline was added to a nebulizer and inhaled for 3-5 minutes in the presence of 4-6 liters/minute of oxygen.

DRUG

Iv Lidocaine

Intravenous %2 lidocaine was administered before induction of anesthesia.

Trial Locations (1)

41900

Derince Training and Research Hospital, Kocaeli

All Listed Sponsors
lead

Derince Training and Research Hospital

OTHER

NCT06107543 - Lidocaine in the Prevention of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation | Biotech Hunter | Biotech Hunter